Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab

NCT02386566 · clinicaltrials.gov ↗
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen